This publication is about entering into non-exclusive discount contracts according to § 130a Abs. 8 SGB V for finished medicines containing the active ingredient Abaloparatide (ATC: H05AA04) as part of an "open-house model". Under uniform contract conditions and a standardized access procedure, all
378 days left to bid. Opened 11 months ago, deadline 30 Oct 2027.
This contract opportunity involves the establishment of non-exclusive discount agreements for finished medications containing the active ingredient Timolol (ATC: S01ED01) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to enter into or join
This contract opportunity involves the establishment of non-exclusive discount agreements for finished pharmaceuticals containing the active ingredient Rivaroxaban (ATC: B01AF01 - in all strengths except 2.5 mg per divided oral dosage form) under an 'open-house model'. All eligible and interested ph
This contract opportunity involves the establishment of non-exclusive discount agreements for finished medicines containing the active ingredients Tramadol and Paracetamol (ATC: N02AJ13) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to ent
This contract involves the delivery of natural gas, including network usage, to the buyer's facilities starting from January 1, 2026, at 6:00 AM. Suppliers are invited to provide proposals for the supply of natural gas to AOK Sachsen-Anhalt. The deadline for submissions is July 22, 2025. For more de
Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
Opportunity to provide a digital mental health platform delivering NICE-recommended therapeutic interventions and resources for children, young people, and families in South Staffordshire.
Opportunity for Primary Care Networks to deliver integrated COPD identification and specialist support services using digital risk stratification across Hull and East Yorkshire communities.
